We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$303M
AUM Growth
+$47.8M
(+19%)
Cap. Flow
+$22.2M
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
115
New
28
Increased
31
Reduced
37
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$9.42M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$5.8M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$5.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$4.11M |
| 5 |
Baxter International
BAX
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Encompass Health
EHC
|
+$7.11M |
| 2 |
Universal Health Services
UHS
|
+$5.84M |
| 3 |
Quest Diagnostics
DGX
|
+$5.57M |
| 4 |
Community Health Systems
CYH
|
+$4.33M |
| 5 |
Elevance Health
ELV
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.89% |
| 2 | Financials | 0.91% |
| 3 | Technology | 0.66% |
| 4 | Consumer Staples | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Universal Health Services
UHS
$10.2B
| $3.87M | 1.28% |
32,875
-52,800
| -62% | -$5.84M |
|
27
Intuitive Surgical
ISRG
$127B
| $3.84M | 1.27% |
68,400
+57,735
| +541% | +$3.27M |
|
28
Revvity
RVTY
$12.6B
| $3.78M | 1.25% |
73,950
+15,950
| +28% | +$739K |
|
29
Biogen
BIIB
$30B
| $3.72M | 1.23% |
8,812
-800
| -8% | -$315K |
|
|
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.71M | 1.22% |
363,678
+278,274
| +326% | +$3.41M |
|
|
KTWO
31
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.6M | 1.19% |
+163,122
| New | +$3.34M |
|
32
Danaher
DHR
$137B
| $3.48M | 1.15% |
61,076
+40,470
| +196% | +$2.32M |
|
|
CELG
33
DELISTED
Celgene Corp
CELG
| $3.45M | 1.14% |
29,960
+14,600
| +95% | +$1.74M |
|
|
MDRX
34
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.42M | 1.13% |
285,550
-3,400
| -1% | -$41.5K |
|
35
Gilead Sciences
GILD
$162B
| $3.25M | 1.07% |
33,100
+26,500
| +402% | +$2.69M |
|
36
HCA Healthcare
HCA
$87.2B
| $3.23M | 1.07% |
43,000
+32,375
| +305% | +$2.33M |
|
|
37
Encompass Health
EHC
$11B
| $3.12M | 1.03% |
88,479
-207,844
| -70% | -$7.11M |
|
|
MNK
38
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.99M | 0.99% |
23,609
-6,500
| -22% | -$743K |
|
39
Insulet
PODD
$11.5B
| $2.87M | 0.95% |
+86,100
| New | +$2.91M |
|
40
Agilent Technologies
A
$39.1B
| $2.86M | 0.94% |
68,765
+5,700
| +9% | +$231K |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $2.76M | 0.91% |
25,950
+6,800
| +36% | +$666K |
|
42
Waters Corp
WAT
$37B
| $2.75M | 0.91% |
+22,100
| New | +$2.64M |
|
|
MDVN
43
DELISTED
MEDIVATION, INC.
MDVN
| $2.67M | 0.88% |
41,300
-3,600
| -8% | -$206K |
|
44
Tandem Diabetes Care
TNDM
$1.34B
| $2.49M | 0.82% |
+19,765
| New | +$2.57M |
|
|
SLXP
45
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $2.47M | 0.82% |
14,300
-4,800
| -25% | -$705K |
|
46
Merck
MRK
$322B
| $2.46M | 0.81% |
44,860
+1,887
| +4% | +$107K |
|
|
HRC
47
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.36M | 0.78% |
48,250
+2,900
| +6% | +$138K |
|
|
MGLN
48
DELISTED
Magellan Health Services, Inc.
MGLN
| $2.33M | 0.77% |
32,920
+7,100
| +27% | +$447K |
|
49
Amphastar Pharmaceuticals
AMPH
$879M
| $2.28M | 0.75% |
152,159
+45,100
| +42% | +$603K |
|
50
Humana
HUM
$43.7B
| $2.21M | 0.73% |
12,398
-2,900
| -19% | -$459K |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Endurant Capital Management held 115 positions worth $303M, up 19% from $255M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Endurant Capital Management deployed $22.2M of net new capital in Q1 2015, opening 28 new positions and adding to 31 existing holdings. Its largest new stake was Express Scripts Holding Company: 69,200 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Encompass Health, an estimated $7.11M trimmed.
- Endurant Capital Management's largest Q1 2015 buy was Express Scripts Holding Company: 69,200 shares worth $6M.
- Endurant Capital Management added most to Globus Medical in Q1 2015, an estimated $9.42M increase.
- Endurant Capital Management's biggest Q1 2015 reduction was Encompass Health, cutting an estimated $7.11M.
- Endurant Capital Management fully exited Quest Diagnostics in Q1 2015, selling an estimated $5.57M.
- Endurant Capital Management's ten largest holdings make up 35% of its $303M portfolio in Q1 2015.
- Endurant Capital Management opened 28 new positions and closed 19 in Q1 2015.
- Endurant Capital Management's portfolio value rose 19% quarter-over-quarter to $303M.
Based on Endurant Capital Management's 13F filing for Q1 2015, filed 15 May 2015.